BEXIMCO PHARMA.GDR REGS 1 (R2WA) — Free Cash Flow Generation Index
BEXIMCO PHARMA.GDR REGS 1 (R2WA) has a Free Cash Flow Generation Index of 0.73x as of June 2024. Free cash flow of €6.13 Billion represents 1% of operating cash flow (€8.36 Billion). Explore BEXIMCO PHARMA.GDR REGS 1 (R2WA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BEXIMCO PHARMA.GDR REGS 1 Free Cash Flow Generation Index (2022–2024)
Historical FCF Generation Index trend for BEXIMCO PHARMA.GDR REGS 1 across 3 annual periods. For the full cash flow conversion analysis, see BEXIMCO PHARMA.GDR REGS 1 (R2WA) cash conversion ratio.
Annual Free Cash Flow Generation for BEXIMCO PHARMA.GDR REGS 1 (2022–2024)
Year-by-year Free Cash Flow Generation Index for BEXIMCO PHARMA.GDR REGS 1. Check R2WA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.73x | €6.13 Billion | €8.36 Billion | €2.23 Billion | ▲ +32.1% |
| 2023 | 0.55x | €3.37 Billion | €6.08 Billion | €2.71 Billion | ▲ +27.1% |
| 2022 | 0.44x | €2.27 Billion | €5.21 Billion | €2.94 Billion | — |